Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.
Xaira Therapeutics has raised $1.0B in total funding. The most recent round was Series A. The last funding was announced in April 2024.
Xaira Therapeutics's investors include Menlo Ventures, Lightspeed Venture Partners, Sequoia Capital, ARCH Venture Partners, Lux Capital.
Xaira Therapeutics is headquartered in South San Francisco, United States.
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.
Xaira Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xaira Therapeutics — Funding & Investors." VCBacked, April 23, 2024, https://www.vcbacked.co/company/xaira-therapeutics. Accessed July 19, 2026.
VCBacked. (2024). Xaira Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/xaira-therapeutics
{{cite web |title=Xaira Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/xaira-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated